Do Probiotics Actually Help Bladder Health?

HerWellReport is reader-supported. We may earn a commission from links on this page at no extra cost to you — see our affiliate disclosure. This article is information, not medical advice; please read our medical disclaimer.

Almost every bladder supplement aimed at women over 45 now leads with the same idea: your bladder has its own community of bacteria, menopause has depleted the good ones, and a daily capsule of Lactobacillus will put them back. It is a tidy story, and the first half of it is true.

The second half has never been tested in the form it is sold. That is the honest position, and it is worth understanding properly — because the science underneath is genuinely interesting, and because knowing where it stops tells you exactly what a probiotic capsule can and cannot be expected to do.

What the science really found: urine is not sterile

For most of the twentieth century, medicine held that healthy urine was sterile. That turned out to be an artefact of how urine was cultured. In a 2014 study, researchers used an expanded culture technique on 65 urine samples and grew bacteria from 52 of them — and 48 of those 52 had been reported as “no growth” by standard laboratory culture.¹ They identified 35 genera and 85 species, with Lactobacillus the single most prevalent genus at 15%.¹

A later study isolated and sequenced 149 bacterial strains from catheterised urine in 77 women, covering around two-thirds of the bacterial diversity present. It also found that the bladder and vaginal communities are closely linked: within the same woman, Lactobacillus iners strains were 99.99% similar between vagina and bladder, and L. crispatus 99.80% similar.²

That is the real discovery, and we cover it fully in what is the urinary microbiome. Note what it is: a description of what lives there, obtained by catheter and DNA sequencing. Nobody in those studies took a supplement.

Lactobacillus and infection risk: a real association

The link between vaginal lactobacilli and lower urinary tract infection risk is well documented. Women with recurrent UTIs who lacked hydrogen-peroxide-producing vaginal lactobacilli had a fivefold increased risk of vaginal E. coli colonisation compared with women who had them.³ In a comparison of 301 women, 15% of those colonised with L. crispatus or L. jensenii carried E. coli, against 27% of women without those species.³

These are associations. A 2025 review in the International Urogynecology Journal makes the limit explicit: reduced vaginal Lactobacillus correlates with more urinary pathogens, but the role of that relationship in recurrent and chronic UTI “remains uncertain” and the mechanisms are more complex than first assumed.⁴

The part that decides everything: swallowed or inserted

Here is where the marketing and the evidence part company. The strongest Lactobacillus trial for recurrent UTI used a suppository placed in the vagina, not a capsule swallowed into the gut.

The intravaginal trial. A phase 2 randomised placebo-controlled trial gave 100 premenopausal women with recurrent UTI an intravaginal L. crispatus preparation daily for 5 days then weekly for 10 weeks. Recurrent UTI occurred in 7 of 48 women on the probiotic (15%) versus 13 of 48 on placebo (27%) — a risk ratio of 0.5, with a 95% confidence interval of 0.2 to 1.2.⁵ That interval crosses 1, which means the primary result was a favourable trend rather than a statistically significant one. The authors’ own conclusion called for larger efficacy trials.⁵ Fifteen years later, neither the European nor the American guidelines record a confirmatory trial.⁶⁷

The oral trial. The largest test of an oral capsule ran in 252 postmenopausal women with recurrent UTI, comparing twice-daily capsules containing at least a billion colony-forming units of L. rhamnosus GR-1 and L. reuteri RC-14 against a preventive antibiotic, over 12 months. Mean symptomatic UTIs were 1.2 on the antibiotic and 1.8 on the lactobacilli — the probiotic did not meet the trial’s non-inferiority threshold.⁸ The trial did show one genuine advantage: antibiotic resistance climbed steeply in the antibiotic arm and did not change in the probiotic arm.⁸ But on the question that matters here, the reported vaginal flora scores did not significantly change from baseline in either group.⁸

The pooled picture. A Cochrane review of 9 studies in 735 people found that compared with placebo, probiotics produced no significant reduction in recurrent symptomatic UTI — risk ratio 0.82, 95% confidence interval 0.60 to 1.12, across 6 studies and 352 participants. The reviewers noted small sample sizes, insufficient methodological detail and an overall high risk of bias, and were careful to add that a benefit cannot be ruled out either; the data are simply too thin to settle it.⁹

So the honest sentence, which you will not find on a supplement label: no published trial has shown that swallowing a Lactobacillus capsule changes what lives in the bladder. The one route that produced measurable colonisation put the bacteria where they were meant to end up.⁵

And for leaking, urgency or getting up at night?

This is the section that matters most, because leaking and urgency are what most women are actually buying a bladder supplement for.

A 2025 systematic review examined 21 studies of the urinary microbiome in urgency incontinence, overactive bladder and stress incontinence. It found consistent associations — lower Lactobacillus levels, more Gardnerella, particularly in urgency incontinence, and an inverse correlation between Lactobacillus levels and symptom severity.¹⁰ But of those 21 studies, exactly one was an intervention study, and it tested a topical feminine hygiene product rather than an oral supplement. The reviewers listed “insufficient causal evidence” among the field’s core limitations.¹⁰

There is a further irony worth noting. The foundational “urine is not sterile” work was done largely in women with overactive bladder, and Lactobacillus was the most common genus found in that group.¹ Presence is not protection.

If leaking or urgency is your actual problem, the interventions with guideline backing are bladder training and supervised pelvic floor work — see why you leak when you sneeze for how those differ by leak type, or take the symptom check if you are not sure which you have.

Why “contains Lactobacillus” tells you almost nothing

Probiotic effects are strain-specific. The US National Institutes of Health’s own guidance states that because effects can be specific to particular strains, recommendations need to be strain-specific.¹¹ The European guideline reflects that precisely: it names L. rhamnosus GR-1, L. reuteri B-54 and RC-14, L. casei shirota and L. crispatus CTV-05 — strain designations, not species — and gives probiotics a weak recommendation, adding that data on optimal dose, route and duration remain insufficient.⁶

The scientific association for probiotics says a label should carry the genus, species and strain for each organism, plus the minimum viable count at the end of shelf life. It flags counts stated at time of manufacture as a real problem, since viable numbers decline in the bottle.¹² The regulatory reason labels are often uninformative: current labelling rules require only the total weight of the microorganisms, which can include dead ones, so the figure has no reliable relationship to the number of live organisms you are getting.¹¹

Practical translation: a label that says “crispatus, acidophilus, plantarum, gasseri, casei” gives you species names only. The evidence attaches to specific strains within some of those species. Without a strain code and a count guaranteed to the end of shelf life, you cannot map the product onto any published trial. This is one of several reasons we set out what is and is not disclosed on the FemiCore ingredients page.

What a supplement actually has to prove

Less than most buyers assume. The US Food and Drug Administration does not have the authority to approve dietary supplements before they are marketed; responsibility for safety sits with the manufacturer.¹³ Structure-function claims can be made without FDA authorisation provided the firm holds substantiation and carries the standard disclaimer that the statement has not been evaluated by the FDA and the product is not intended to diagnose, treat, cure or prevent any disease.¹³

Advertising is governed separately. The Federal Trade Commission requires “competent and reliable scientific evidence,” states that randomised controlled human trials are the most reliable form and generally what experts would require for a health benefit claim, and — crucially for this subject — asks whether the dose and formulation of the advertised product match what was used in the study, whether the ingredients are the same, and whether the study population reflects the people being advertised to.¹⁴

That last test is exactly where “repopulates your urinary microbiome” fails. The colonisation data come from a vaginal suppository in premenopausal women; the product is an oral capsule sold to women over 45.⁵¹⁴

The menopause angle — and what has better evidence

The biology behind the marketing is sound. Oestrogen thickens the vaginal lining and drives glycogen deposition, which lactobacilli feed on. After menopause, higher vaginal pH follows falling oestrogen and Lactobacillus levels drop; postmenopausal women show markedly lower proportions of it. The same shift shows up in urine, where menopause increases diversity and lowers the Lactobacillus share — and those changes precede recurrent cystitis.¹⁵ We go through this in perimenopause and your bladder.

What is worth knowing is which intervention has actually been shown to reverse it. In the comparison reported in that review, vaginal pH and lactobacilli were restored to premenopausal levels in women receiving hormone therapy, while no significant changes were observed in the isoflavone or probiotic monotherapy groups.¹⁵

On hard outcomes, Cochrane found vaginal oestrogen reduced UTIs in postmenopausal women with recurrent infection in two studies — risk ratios of 0.25 and 0.64 — while oral oestrogen did not reduce UTI compared with placebo across 4 studies and 2,798 women.¹⁶ European guidance gives vaginal oestrogen a strong recommendation for preventing recurrent UTI where probiotics get a weak one,⁶ and the 2025 American guideline says clinicians should recommend vaginal oestrogen therapy absent a contraindication.⁷

Notice the pattern, because it appears twice in this article. For oestrogen, the oral route failed and the local route worked.¹⁶ For Lactobacillus, the intravaginal route produced colonisation and a favourable trend while the oral route did not.⁵⁸ Route is not a technicality. In this subject it is the finding.

Vaginal oestrogen is a prescription decision with its own trade-offs — Cochrane lists breast tenderness, spotting, discharge, irritation, burning and itching among reported effects.¹⁶ It is a conversation with a clinician, not a swap you make on your own. There is more in recurrent UTIs in women.

Are probiotics safe?

For most healthy people, yes — probiotics are unlikely to cause harm and side effects are usually minor.¹¹ That is worth saying plainly before the caveat.

The caveat is that probiotic use has been linked to bacteraemia, fungaemia and infections resulting in severe illness, mostly in people who were severely ill or immunocompromised, and the risk of harmful effects is greater in that group.¹¹¹⁷ Serious infections have been reported in premature infants given probiotics, prompting an FDA warning to healthcare providers.¹⁷ And few studies have examined probiotic safety in detail, so there is a genuine lack of information on how often and how severely side effects occur.¹⁷

If you are on immunosuppressants, have had a transplant, are having chemotherapy, or have an indwelling catheter or central line, check with your clinician before starting one. “Natural” is not a safety category — as we set out in supplements versus prescription, the honest framing is a different side-effect profile, not no side effects.

Common questions

Will a probiotic capsule put good bacteria back in my bladder?

No trial has shown that. The bladder does carry its own bacteria and Lactobacillus is among the commonest, but that came from sequencing catheterised urine, not from anyone taking a supplement.¹² The study that did measurably raise L. crispatus used a vaginal suppository, and the largest oral-capsule trial in postmenopausal women reported no significant change in vaginal flora.⁵⁸

Do probiotics prevent recurrent UTIs?

The pooled Cochrane result is no significant reduction versus placebo — risk ratio 0.82, 95% confidence interval 0.60 to 1.12 — with a high risk of bias across the included trials, and the reviewers noted that a benefit cannot be ruled out either.⁹ European guidelines still list probiotics as a weak recommendation, and only for strains of proven efficacy.⁶

Can a probiotic help with leaking or urgency?

There is no randomised trial evidence for that. A 2025 systematic review of 21 urinary microbiome studies in incontinence and overactive bladder found a single intervention study among them, of a topical product, and cited insufficient causal evidence as a limitation of the field.¹⁰

Does it matter which strain I take?

Yes, considerably. Effects are strain-specific, and the European guideline names particular strain codes rather than species.¹¹⁶ A label listing only species names, without strain designations and an end-of-shelf-life count, cannot be matched to any published trial.¹²

So is there any point taking one?

That depends on what you expect from it. For a healthy woman, the safety bar is low and the cost is the main consideration.¹¹ But if you are buying it to stop leaks or to change your bladder’s bacteria, the evidence for that has not been produced, and the interventions that do have guideline support are different ones.¹⁰⁶⁷ If you have decided to try something anyway and are simply choosing between products, our guide to bladder control supplements for women puts the common formulas side by side and is blunt about how little most labels actually disclose.

Bottom line

The urinary microbiome is real, and the association between Lactobacillus and a healthier bladder environment is real. What has not been demonstrated is that a capsule swallowed into the gut changes any of it. The best UTI result for L. crispatus came from a vaginal suppository and did not reach statistical significance; the largest oral trial in postmenopausal women failed its non-inferiority test and moved no flora marker; and for leaking and urgency there is essentially no interventional evidence at all. If you take one, take it knowing that. And if your real problem is recurrent infection after menopause, vaginal oestrogen is the option carrying the strong guideline recommendation — worth raising with your GP.

This article is for information only and is not medical advice. Speak to your GP before starting a supplement, particularly if you take prescription medicines or have a condition affecting your immune system.

More from HerWellReport

• What is the urinary microbiome?
• Does cranberry actually help urinary health?
• Recurrent UTIs in women: why they keep coming back
• Bladder control supplements: what is actually in them
• Bladder supplement side effects and drug interactions